Hypersensitivity Type I, II, III and IV in one table
|
S.N. |
Character | Type I | Type II | Type III |
Type IV |
| 1. | Alternative Name | Allergic hypersensitivity | Cytotoxic hypersensitivity | Immune complex hypersensitivity | Cell mediated hypersensitivity/ Delayed type of hypersensitivity |
| 2. | Principle | Antibody mediated degranulation of granulocytes leading to destruction of cells. | Antibody mediated destruction of healthy cells. | Antigen-antibody complex mediated destruction of cells. | T lymphocytes mediated destruction of cells. |
| 3. | Primary Mediator | IgE | IgG/IgM | IgG/IgM | Specific subsets of CD4+ helper T cells or CD8+ cytotoxic T cells. |
| 4. | Other components as mediators | Mast cells, Basophils, histamine & other pharmacological agents | Complement, Neutrophils | Complement, phagocytes and K cells | Dendritic cells, macrophages and cytokines |
| 5. | Reaction time | Immediate or within few hours | 5-8 hours | 2-8 hours | After 24 hours only, mostly 48-72 hours after contact |
| 6. | Antigen | Free in circulation (Soluble) | Fixed on cells | Free in circulation ( Soluble) | Soluble or cell bound |
| 7. | Antigen origin | Exogenous | Endogenous or exogenous | Exogenous or endogenous | Exogenous or endogenous |
| 8. | Antibody | Fixed on mast cells and basophils | Free in circulation | Free in circulation | Not applicable |
| 9. | Mechanism | Allergen-specific IgE antibodies bind to mast cells via their Fc receptor. When the specific allergen binds to the IgE, cross-linking of IgE induces degranulation of mast cells. | IgG or IgM antibody binds to cellular antigen, leading to complement activation and cell lysis. IgG can also mediate ADCC with cytotoxic T cells, natural killer cells, macrophages, and neutrophils. | Antigen-antibody complexes are deposited in tissues. Complement activation provides inflammatory mediators and recruits neutrophils. Enzymes released from neutrophils damage tissue. | Th2 cells secrete cytokines, which activate macrophages and cytotoxic T cells. |
| 10. | Complement activation | No | Yes | Yes | No |
| 11. | Appearance | Weal & flare | Lysis & necrosis | Erythema & edema | Erythema & induration |
| 12. | Transfer with serum | Passive transfer possible with serum | Passive transfer | Passive transfer | Cannot be transferred with serum; but possible with T cells transfer |
| 13. | Desensitization | Easy but short lived | Easy but short lived | Easy but short lived | Difficult but long lived. |
| 14. | Examples | Asthma, Rhinitis, Atopic eczema, Bee sting reaction | Rhesus incompatibility (Rh hemolytic disease), Transfusion Reactions, Cell Destruction due to autoantigens, Drug Induced Hemolytic Anemia | Glomerulonephritis, Systemic Lupus Erythematosus, Farmer’s lung arthritis, Vasculitis | The tuberculin reaction,
Granuloma formation, Allergic contact dermatitis, Type-1 diabetes |
References
- https://courses.lumenlearning.com/microbiology/chapter/hypersensitivities/
- http://www.biologydiscussion.com/immunology/4-main-types-of-hypersensitivity-immunology/61851
- https://www.slideshare.net/drsomeshwaranamsana/hypersensitivity-reactions-dr-somesh-microbiology
- http://www.yourarticlelibrary.com/immunology/type-iii-hypersensitivity-and-its-mechanism-human-immunology/28081
- Lydyard, P.M., Whelan,A.,& Fanger,M.W. (2005).Immunology (2 ed.).London: BIOS Scientific Publishers.
- Owen, J. A., Punt, J., & Stranford, S. A. (2013). Kuby Immunology (7 ed.). New York: W.H. Freeman and Company.
Hypersensitivity Type I, II, III and IV in one table
(Visited 560 times, 1 visits today)